Flavoxate

# Flavoxate ## Overview - **Classification**: Urinary Antispasmodic, Smooth Muscle Relaxant - **Mechanism**: Exerts a direct spasmolytic effect on smooth muscle cells of the urinary tract. Also has local anesthetic properties. ## Primary Indications 1. **Symptomatic Relief of Lower Urinary Tract Irritation**: Dysuria, urgency, nocturia, suprapubic pain, frequency, incontinence. 2. **Associated Conditions**: Cystitis, prostatitis, urethritis, urethrocystitis. 3. **Procedural Relief**: Symptoms secondary to urological diagnostic procedures or surgery. ## Adult Dosing ### Standard Dosing **Symptomatic Relief of Lower Urinary Tract Irritation** - **Dose**: **100 mg** to **200 mg** - **Frequency**: **3 to 4 times a day** - **Route**: Oral ### Dose Adjustments - **Renal Impairment**: Use with **caution**. No specific dose adjustment guidelines provided; consider lower doses. - **Hepatic Impairment**: Use with **caution**. No specific dose adjustment guidelines provided. - **Elderly Patients**: Start at the **lower end** of the dosing range due to potential for decreased organ function and increased sensitivity to anticholinergic effects. ## Pediatric Dosing ### Neonates (0-28 days) - **Dose**: **Not recommended**. - **Special Notes**: Safety and efficacy not established. ### Infants (1-12 months) - **Dose**: **Not recommended**. - **Special Notes**: Safety and efficacy not established. ### Children (1-11 years) - **Dose**: **Not recommended**. - **Special Notes**: Safety and efficacy not established. ### Adolescents (12-18 years) - **Dose**: **100 mg** to **200 mg** - **Frequency**: **3 to 4 times a day** - **Maximum**: **800 mg/day** (as for adults). ## Safety Information ### Contraindications - **Absolute**: Pyloric or duodenal obstruction, obstructive intestinal lesions. - **Absolute**: Paralytic ileus, gastrointestinal hemorrhage, achalasia. - **Absolute**: Obstructive uropathy, urinary tract obstruction. - **Absolute**: Hypersensitivity to flavoxate. ### Common Adverse Effects - **Common (1-10%)**: Nausea, vomiting, dry mouth, headache, dizziness. - **Common (1-10%)**: Blurred vision, nervousness, dyspepsia. - **Serious but Rare**: Tachycardia, palpitations, mental confusion (especially in elderly). ### Key Drug Interactions - **Anticholinergic Agents**: Increased risk of anticholinergic side effects (e.g., dry mouth, constipation, urinary retention). Monitor closely for additive effects. - **Potassium Chloride (Oral Solids)**: Increased risk of GI lesions due to delayed gastric emptying. Avoid concomitant use. ## Monitoring & Follow-up - **Before Treatment**: Rule out underlying bacterial infection if symptoms suggest. Assess for obstructive conditions. - **During Treatment**: Monitor for symptom relief and adverse effects (e.g., urinary retention, vision changes). - **Clinical Signs**: Watch for worsening urinary retention, significant GI upset, vision changes, confusion. ## Clinical Pearls - 💡 **Symptomatic Relief**: Flavoxate addresses symptoms, not the underlying cause. Ensure proper diagnosis and treatment of infections. - 💡 **Driving Precaution**: May cause blurred vision or dizziness; caution patients about operating machinery. - 💡 **Onset of Action**: Symptomatic relief typically occurs within **30-60 minutes**. - 💡 **Hydration**: Encourage adequate fluid intake unless medically contraindicated. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.